It inhibited the proliferation, migration, and invasion of GBM cells, promoting cell apoptosis and negatively regulating the IL-6/JAK2/STAT3 signaling pathway, thereby improving the therapeutic efficacy of GBM. This evidence concerns the gene IL6 and glioblastoma.